Hantz Financial Services Inc. Decreases Stock Position in The Cooper Companies, Inc. $COO

Hantz Financial Services Inc. lessened its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 6.7% during the 2nd quarter, Holdings Channel reports. The firm owned 88,103 shares of the medical device company’s stock after selling 6,328 shares during the quarter. Hantz Financial Services Inc.’s holdings in Cooper Companies were worth $6,269,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently bought and sold shares of the company. Zions Bancorporation National Association UT purchased a new stake in Cooper Companies during the 1st quarter worth approximately $33,000. GKV Capital Management Co. Inc. purchased a new stake in Cooper Companies during the 1st quarter worth approximately $40,000. J.Safra Asset Management Corp grew its position in Cooper Companies by 204.8% during the 2nd quarter. J.Safra Asset Management Corp now owns 506 shares of the medical device company’s stock worth $36,000 after purchasing an additional 340 shares during the last quarter. Larson Financial Group LLC grew its position in Cooper Companies by 1,071.0% during the 1st quarter. Larson Financial Group LLC now owns 726 shares of the medical device company’s stock worth $61,000 after purchasing an additional 664 shares during the last quarter. Finally, HM Payson & Co. grew its position in Cooper Companies by 147.4% during the 1st quarter. HM Payson & Co. now owns 893 shares of the medical device company’s stock worth $75,000 after purchasing an additional 532 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Performance

Shares of NASDAQ COO opened at $70.11 on Friday. The company’s fifty day moving average price is $69.48 and its 200 day moving average price is $73.08. The Cooper Companies, Inc. has a 1 year low of $61.78 and a 1 year high of $107.84. The company has a market capitalization of $13.94 billion, a PE ratio of 34.54, a price-to-earnings-growth ratio of 1.83 and a beta of 1.02. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 2.12.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.07 by $0.03. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The firm had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.06 billion. During the same period in the prior year, the firm posted $0.96 earnings per share. The firm’s quarterly revenue was up 5.7% compared to the same quarter last year. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. On average, research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies declared that its board has authorized a share buyback program on Wednesday, September 17th that authorizes the company to buyback $2.00 billion in shares. This buyback authorization authorizes the medical device company to purchase up to 15.4% of its stock through open market purchases. Stock buyback programs are typically a sign that the company’s board believes its stock is undervalued.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on COO shares. Barclays started coverage on shares of Cooper Companies in a research report on Monday, October 13th. They set an “overweight” rating and a $85.00 target price on the stock. Wells Fargo & Company dropped their target price on shares of Cooper Companies from $93.00 to $72.00 and set an “overweight” rating on the stock in a research report on Thursday, August 28th. Morgan Stanley set a $76.00 price objective on shares of Cooper Companies and gave the company an “equal weight” rating in a report on Thursday, August 28th. Wall Street Zen downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Saturday, July 12th. Finally, The Goldman Sachs Group set a $64.00 price objective on shares of Cooper Companies and gave the company a “sell” rating in a report on Wednesday, October 1st. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $84.77.

Insider Activity

In other news, COO Gerard H. Warner III purchased 1,450 shares of the stock in a transaction that occurred on Friday, September 5th. The shares were purchased at an average cost of $69.23 per share, with a total value of $100,383.50. Following the completion of the acquisition, the chief operating officer owned 18,319 shares of the company’s stock, valued at approximately $1,268,224.37. This represents a 8.60% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Brian G. Andrews purchased 1,525 shares of the stock in a transaction that occurred on Tuesday, September 2nd. The shares were purchased at an average cost of $65.68 per share, for a total transaction of $100,162.00. Following the completion of the acquisition, the executive vice president directly owned 22,191 shares of the company’s stock, valued at $1,457,504.88. This represents a 7.38% increase in their position. The SEC filing for this purchase provides additional information. Insiders bought a total of 17,975 shares of company stock valued at $1,216,346 in the last three months. Corporate insiders own 1.98% of the company’s stock.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.